Investing in the cannabis sector can seem risky these days, as the Horizons Marijuana Life Sciences ETF has plummeted more than 50% in just one year, while the S&P 500 has risen by 13%. No excitement on the legalization front and investors growing jittery amid the…
potential for several interest rate increases this year has sent them looking for shelter in safer, more value-oriented investments.
But if you’re willing to stick with the cannabis industry for the long haul, there could be some incredible opportunities to buy some promising stocks right now. Columbia Care ( CCHWF -6.04% ), Cresco Labs ( CRLBF -9.88% ), and GrowGeneration ( GRWG 5.47% ) are all trading near their 52-week lows. And these businesses could see much better days as the industry expands in the years ahead.
1. Columbia Care
Multistate marijuana operator Columbia Care has 99 dispensaries across the country and is continuing to grow. In its most recent results, for the period ending Sept. 30, 2021, sales of $132.3 million were up 144% year over year, and its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) profit of $31 million meant its bottom line was an impressive 23% of sales.
The company has locations in two promising states that recently legalized recreational marijuana, New York and New Jersey, which could help position it for even more growth down the road.
What’s attractive about Columbia Care is that this is one of the more innovative pot stocks out there. In 2019, it launched its own credit card, which is unique in an illicit industry where customers often need to rely on making payments with cash. In April 2020, the early stages of the pandemic, it launched a virtual shopping experience where “on-site experts” would help customers shop from the convenience of their own home.
Innovative, growing, and profitable, Columbia Care makes for an underrated investment in the sector. At a price-to-sales (P/S) multiple of just over 2, it’s also slightly cheaper than more popular stocks like Curaleaf Holdings or Trulieve Cannabis, which trade at more than three times their revenue. At less than a dollar from its 52-week low, Columbia Care could be a solid pickup for investors.
2. Cresco Labs
Cresco Labs is a stock I’ve been a fan of for some time because it is growing while also keeping its bottom line strong. And that’s partly because the company is strategic in where it picks its spots to set up shop. A great example of that is its location near Wrigley Field, home of the Chicago Cubs. The company opened that location in November 2021, and with many baseball games and other events nearby, it has the potential to draw in lots of customers.
Being selective in where it opens dispensaries can help keep costs low while still tapping into a market’s growth potential. Cresco Labs has a relatively modest 48 retail locations across the country. By comparison, Trulieve has more than 110 locations just in Florida alone.
Cresco’s strategy has been working well for the business. In its third-quarter results (period ending Sept. 30, 2021), its revenue of $215.5 million was up 41% year over year. Its adjusted EBITDA profit totaled $56.4 million, for a margin of more than 26%.
Like Columbia Care, Cresco also isn’t far from its 52-week low. And its P/S ratio is barely above 2, trading at even less of a premium.
GrowGeneration is the only company on this list that isn’t a pot producer. Instead, it’s in the business of helping producers cultivate cannabis. It says it’s “where the pros go to grow,” selling grow lights, tents, water pumps, and many other related things growers require. While cannabis isn’t the only thing its products can help grow…
Continue reading at THE MOTLEY FOOL